脉络膜毛细血管流空的临床应用研究进展

doi:10.11958/20221642

天津医药 ›› 2023, Vol. 51 ›› Issue (4): 445-448.doi: 10.11958/20221642

• 综述 • 上一篇

脉络膜毛细血管流空的临床应用研究进展

毕萌¹^,²(), 樊芳¹, 贾志旸¹^,^△()

1 河北省人民医院眼科（邮编050051）
2 华北理工大学研究生院

收稿日期:2022-10-17 修回日期:2022-12-21 出版日期:2023-04-15 发布日期:2023-04-20
通讯作者: 贾志旸 E-mail:layla_b@163.com;jiazhiyang2079@sina.com
作者简介:毕萌（1997），女，硕士在读，主要从事白内障、玻璃体视网膜疾病方面研究。E-mail：layla_b@163.com
基金资助:
河北省医学适用技术跟踪项目(GZ2021040)

Research progress in clinical application of choroid capillary flow deficits

BI Meng¹^,²(), FAN Fang¹, JIA Zhiyang¹^,^△()

1 Department of Ophthalmology, Hebei General Hospital, Shijiazhuang 050051, China
2 Graduate School, North China University of Science and Technology

Received:2022-10-17 Revised:2022-12-21 Published:2023-04-15 Online:2023-04-20
Contact: JIA Zhiyang E-mail:layla_b@163.com;jiazhiyang2079@sina.com

毕萌, 樊芳, 贾志旸. 脉络膜毛细血管流空的临床应用研究进展[J]. 天津医药, 2023, 51(4): 445-448.

BI Meng, FAN Fang, JIA Zhiyang. Research progress in clinical application of choroid capillary flow deficits[J]. Tianjin Medical Journal, 2023, 51(4): 445-448.

摘要/Abstract

摘要：

随着光学相干断层扫描血管成像技术（OCTA）的发展，运用OCTA定量分析脉络膜毛细血管（CC）情况已经成为一种新兴的评估手段。视网膜及脉络膜等眼部相关疾病的发生发展与脉络膜血管的形态及功能密切相关，尤其与脉络膜毛细血管的变化有关。通过OCTA获得的CC层图像进行二值化处理及量化分析后，可得到测量范围内CC层流空区域数量、面积、百分比等参数，从而评估脉络膜毛细血管血流灌注变化情况，对探索相关疾病的发病机制、疾病的诊断及干预治疗提供一定的帮助。就脉络膜毛细血管流空区域的临床应用研究进展进行综述。

关键词: 脉络膜, 毛细血管, 体层摄影术，光学相干, 脉络膜血流不足, 中心性浆液性视网膜脉络膜病变, 年龄相关性黄斑变性

Abstract:

With the development of optical coherence tomography (optical coherence tomography angiography, OCTA), quantitative study of choriocapillaris (choriocapillaris, CC) has become a novel evaluation method. The occurrence and development of eye diseases, such as retina and choroid are closely related to the morphology and function of choroidal vessels, especially the change of choriocapillaris. The CC flow deficits parameters, such as density, area and number can be obtained after processing and quantitative analysising images of CC layer from OCTA, assess changes in choroid blood capillary perfusion, explore the pathogenesis of related diseases and provide certain help for disease diagnosis and intervention therapy. This paper reviews the clinical application and research progress of choroid capillary flow deficits.

Key words: choroid, choriocapillaris, tomography, optical coherence, choroid flow deficits, central serous chorioretinopathy, age-related macular degeneration

中图分类号:

R773.4

参考文献 40

[1]	BORRELLI E, SARRAF D, FREUND K B, et al. OCT angiography and evaluation of the choroid and choroidal vascular disorders[J]. Prog Retin Eye Res, 2018, 67:30-55. doi:10.1016/j.preteyeres.2018.07.002.
[2]	KRYTKOWSKA E, GRABOWICZ A, MOZOLEWSKA-PIOTROWSKA K, et al. The impact of vascular risk factors on the thickness and volume of the choroid in AMD patients[J]. Sci Rep, 2021, 11(1):15106. doi:10.1038/s41598-021-94676-6.
[3]	KUNG E W T, CHAN V T T, TANG Z, et al. Alterations in the choroidal sublayers in relationship to severity and progression of diabetic retinopathy:A swept-source OCT study[J]. Ophthalmol Sci, 2022, 2(2):100130. doi:10.1016/j.xops.2022.100130.
[4]	BHALLA M, HEISLER M, MAMMO Z, et al. Investigation of the peripapillary choriocapillaris in normal tension glaucoma,primary open-angle glaucoma,and control eyes[J]. J Glaucoma, 2021, 30(8):682-689. doi:10.1097/IJG.0000000000001861.
[5]	KAYE R, CHANDRA S, SHETH J, et al. Central serous chorioretinopathy:An update on risk factors,pathophysiology and imaging modalities[J]. Prog Retin Eye Res, 2020, 79:100865. doi:10.1016/j.preteyeres.2020.100865.
[6]	TIOSANO L, CORRADETTI G, SADDA S R. Progression of choriocapillaris flow deficits in clinically stable intermediate age-related macular degeneration[J]. Eye(Lond), 2021, 35(11):2991-2998. doi:10.1038/s41433-020-01298-9.
[7]	LEJOYEUX R, BENILLOUCHE J, ONG J, et al. Choriocapillaris:Fundamentals and advancements[J]. Prog Retin Eye Res, 2022, 87:100997. doi:10.1016/j.preteyeres.2021.100997.
[8]	ZHOU K, SONG S, ZHANG Q, et al. Visualizing choriocapillaris using swept-source optical coherence tomography angiography with various probe beam sizes[J]. Biomed Opt Express, 2019, 10(6):2847-2860. doi:10.1364/BOE.10.002847.
[9]	SPAIDE R F. Choriocapillaris flow features follow a power law distribution:Implications for characterization and mechanisms of disease progression[J]. Am J Ophthalmol, 2016, 170:58-67. doi:10.1016/j.ajo.2016.07.023.
[10]	YUN C, NAM K T, PARK S, et al. Features of the choriocapillaris on four different optical coherence tomography angiography devices[J]. Int Ophthalmol, 2020, 40(2):325-333. doi:10.1007/s10792-019-01182-w.
[11]	CHU Z, ZHOU H, CHENG Y, et al. Improving visualization and quantitative assessment of choriocapillaris with swept source OCTA through registration and averaging applicable to clinical systems[J]. Sci Rep, 2018, 8(1):16826. doi:10.1038/s41598-018-34826-5.
[12]	SUN G, CHEN C, JIANG J, et al. New insights into the association between choroidal vessels and choriocapillaris in normal eyes[J]. Retina, 2021, 41(12):2612-2619. doi:10.1097/IAE.0000000000003238.
[13]	LIN E, KE M, TAN B, et al. Are choriocapillaris flow void features robust to diurnal variations? A swept-source optical coherence tomography angiography (OCTA)study[J]. Sci Rep, 2020, 10(1):11249. doi:10.1038/s41598-020-68204-x.
[14]	ZHENG F, ZHANG Q, SHI Y, et al. Age-dependent changes in the macular choriocapillaris of normal eyes imaged with swept-source optical coherence tomography angiography[J]. Am J Ophthalmol, 2019, 200:110-122. doi:10.1016/j.ajo.2018.12.025.
[15]	ROCHEPEAU C, KODJIKIAN L, GARCIA M A, et al. Optical coherence tomography angiography quantitative assessment of choriocapillaris blood flow in central serous chorioretinopathy[J]. Am J Ophthalmol, 2018, 194:26-34. doi:10.1016/j.ajo.2018.07.004.
[16]	HO M, LAI F, NG D, et al. Analysis of choriocapillaris perfusion and choroidal layer changes in patients with chronic central serous chorioretinopathy randomised to micropulse laser or photodynamic therapy[J]. Br J Ophthalmol, 2021, 105(4):555-560. doi:10.1136/bjophthalmol-2020-316076.
[17]	NICOLÒ M, ROSA R, MUSETTI D, et al. Choroidal vascular flow area in central serous chorioretinopathy using swept-source optical coherence tomography angiography[J]. Invest Ophthalmol Vis Sci, 2017, 58(4):2002-2010. doi:10.1167/iovs.17-21417.
[18]	YUN C, HUH J, AHN S M, et al. Choriocapillaris flow features and choroidal vasculature in the fellow eyes of patients with acute central serous chorioretinopathy[J]. Graefes Arch Clin Exp Ophthalmol, 2019, 257(1):57-70. doi:10.1007/s00417-018-4179-2.
[19]	XU Y, SU Y, LI L, et al. Effect of photodynamic therapy on optical coherence tomography angiography in eyes with chronic central serous chorioretinopathy[J]. Ophthalmologica, 2017, 237(3):167-172. doi:10.1159/000456676.
[20]	VAN RIJSSEN T J, VAN DIJK E H C, YZER S, et al. Central serous chorioretinopathy:Towards an evidence-based treatment guideline[J]. Prog Retin Eye Res, 2019, 73:100770. doi:10.1016/j.preteyeres.2019.07.003.
[21]	ALAGORIE A R, VERMA A, NASSISI M, et al. Quantitative assessment of choriocapillaris flow deficits surrounding choroidal neovascular membranes[J]. Retina, 2020, 40(11):2106-2112. doi:10.1097/IAE.0000000000002878.
[22]	SEDDON J M, MCLEOD D S, BHUTTO I A, et al. Histopathological insights into choroidal vascular loss in clinically documented cases of age-related macular degeneration[J]. JAMA Ophthalmol, 2016, 134(11):1272-1280. doi:10.1001/jamaophthalmol.2016.3519.
[23]	BORRELLI E, SHI Y, UJI A, et al. Topographic analysis of the choriocapillaris in intermediate age-related macular degeneration[J]. Am J Ophthalmol, 2018, 196:34-43. doi:10.1016/j.ajo.2018.08.014.
[24]	BHUTTO I, LUTTY G. Understanding age-related macular degeneration(AMD):relationships between the photoreceptor/retinal pigment epithelium/Bruch’s membrane/choriocapillaris complex[J]. Mol Aspects Med, 2012, 33(4):295-317. doi:10.1016/j.mam.2012.04.005.
[25]	RO-MASE T, ISHIKO S, OMAE T, et al. Association between alterations of the choriocapillaris microcirculation and visual function and cone photoreceptors in patients with diabetes[J]. Invest Ophthalmol Vis Sci, 2020, 61(6):1. doi:10.1167/iovs.61.6.1.
[26]	CONTI F F, QIN V L, RODRIGUES E B, et al. Choriocapillaris and retinal vascular plexus density of diabetic eyes using split-spectrum amplitude decorrelation spectral-domain optical coherence tomography angiography[J]. Br J Ophthalmol, 2019, 103(4):452-456. doi:10.1136/bjophthalmol-2018-311903.
[27]	LUTTY G A. Diabetic choroidopathy[J]. Vision Res, 2017, 139:161-167. doi:10.1016/j.visres.2017.04.011.
[28]	WANG W, GUO X, CHEN Y, et al. Choriocapillaris perfusion assessed using swept source optical coherence tomographic angiography and the severity of diabetic retinopathy[J]. Br J Ophthalmol, 2022: bjophthalmol-2021-320163. doi:10.1136/bjophthalmol-2021-320163.
[29]	BORRELLI E, PALMIERI M, VIGGIANO P, et al. Photoreceptor damage in diabetic choroidopathy[J]. Retina, 2020, 40(6):1062-1069. doi:10.1097/IAE.0000000000002538.
[30]	AL-SHEIKH M, PHASUKKIJWATANA N, DOLZ-MARCO R, et al. Quantitative OCT angiography of the retinal microvasculature and the choriocapillaris in myopic eyes[J]. Invest Ophthalmol Vis Sci, 2017, 58(4):2063-2069. doi:10.1167/iovs.16-21289.
[31]	SU L, JI Y S, TONG N, et al. Quantitative assessment of the retinal microvasculature and choriocapillaris in myopic patients using swept-source optical coherence tomography angiography[J]. Graefes Arch Clin Exp Ophthalmol, 2020, 258(6):1173-1180. doi:10.1007/s00417-020-04639-2.
[32]	PANG C E, SARRAF D, FREUND K B. Extreme choroidal thinning in high myopia[J]. Retina, 2015, 35(3):407-415. doi:10.1097/IAE.0000000000000368.
[33]	LI J, ZHOU H, FEINSTEIN M, et al. Choriocapillaris changes in myopic macular degeneration[J]. Transl Vis Sci Technol, 2022, 11(2):37. doi:10.1167/tvst.11.2.37.
[34]	UEMATSU S, SAKAGUCHI H, SAYANAGI K, et al. Association between choriocapillaris flow deficit and choroidal neovascularization activity in eyes with myopic choroidal neovascularization[J]. Sci Rep, 2021, 11(1):21947. doi:10.1038/s41598-021-01557-z.
[35]	CHENG W, WANG W, SONG Y, et al. Choriocapillaris and progressive ganglion cell-inner plexiform layer loss in non-glaucomatous eyes[J]. Br J Ophthalmol, 2022: bjophthalmol-2022-321277. doi:10.1136/bjo-2022-321277.
[36]	CHU Z, WEINSTEIN J E, WANG R K, et al. Quantitative analysis of the choriocapillaris in uveitis using en face swept-source optical coherence tomography angiography[J]. Am J Ophthalmol, 2020, 218: 17-27. doi:10.1016/j.ajo.2020.05.006.
[37]	EBRAHIMIADIB N, MALEKI A, FADAKAR K, et al. Vascular abnormalities in uveitis[J]. Surv Ophthalmol, 2021, 66(4):653-667. doi:10.1016/j.survophthal.2020.12.006.
[38]	CICINELLI M V, RITTER M, TAUSIF H, et al. Characterization of choriocapillaris and choroidal abnormalities in alport syndrome[J]. Transl Vis Sci Technol, 2022, 11(3):23. doi:10.1167/tvst.11.3.23.
[39]	SU L, TAWEEBANJONGSIN W, GAW S L, et al. Evaluation of the choroid in women with uncomplicated pregnancy[J]. Transl Vis Sci Technol, 2020, 9(9):24. doi:10.1167/tvst.9.9.24.
[40]	CHUA J, LE T T, TAN B, et al. Choriocapillaris microvasculature dysfunction in systemic hypertension[J]. Sci Rep, 2021, 11(1):4603. doi:10.1038/s41598-021-84136-6.

脉络膜毛细血管流空的临床应用研究进展

Research progress in clinical application of choroid capillary flow deficits

引用本文

RichHTML

PDF (PC)

可视化

摘要/Abstract

使用本文

参考文献 40

相关文章 14

编辑推荐

Metrics

本文评价

[1]	马良, 胡立影, 石羽, 龙刚. 光学相干断层扫描血管成像技术在慢性肾脏病临床评估中的应用进展[J]. 天津医药, 2024, 52(8): 882-887.
[2]	郭玉峰, 刘玉梅, 毕秀增, 郭俊麟, 孙莉, 王维秀, 杨定位. 成人肾病综合征患者黄斑区视网膜厚度与尿蛋白的相关性研究[J]. 天津医药, 2023, 51(8): 869-872.
[3]	张丽君, 李翔威, 谭晓慧. 单侧湿性年龄相关性黄斑变性患者患眼黄斑区GCIPL厚度变化及其与血清IL-8水平的关系[J]. 天津医药, 2023, 51(2): 166-170.
[4]	许雪妹, 李春艳, 邓志鸿, 徐小明, 石晶. 原发性3级高血压患者黄斑区脉络膜厚度分析[J]. 天津医药, 2023, 51(2): 176-179.
[5]	肖博文, 曹维, 刘莉静, 赵香, 王昕. 糖皮质激素联合降眼压药物治疗病理性近视合并多灶性脉络膜炎的临床疗效观察[J]. 天津医药, 2023, 51(1): 54-57.
[6]	杨俊峰, 曾培, 杜琛, 江枫, 张瑞, 李晓文, 张超, 王春阳, △. 托珠单抗和硫唑嘌呤对NMOSD患者视神经炎后视神经变化的影响#br#[J]. 天津医药, 2021, 49(1): 32-35.
[7]	任明玉, 吴一湘, 韩瑞娟, 周美美, 李瑞淼, 刘立民. 眼内转移性肿瘤的诊疗分析[J]. 天津医药, 2020, 48(3): 216-219.
[8]	王莎莎, 姜波, Jorge A. Trujillo Perdomo, 廖荣丰△. 多光谱视网膜成像与光学相干断层扫描血管技术在非增殖性糖尿病视网膜病变检查中的应用[J]. 天津医药, 2020, 48(11): 1110-1114.
[9]	庄小垒, 李俊岭, 李茜汝, 丁洪光. 热打击通过活化NLRP3炎性小体增加肺毛细血管的通透性[J]. 天津医药, 2019, 47(11): 1145-1150.
[10]	苏龙 , 汤欣 . 微创引流植入物在青光眼手术中的应用进展[J]. 天津医药, 2018, 46(7): 780-784.
[11]	李文博，胡博杰，李筱荣△. 高度近视的组织学改变研究进展[J]. 天津医药, 2017, 45(6): 657-659.
[12]	魏树瑾1 ,巩鸿霞2 ,孟秀阁1 . 中医治疗渗出型老年性黄斑变性一例[J]. , 2011, 39(7): 670-671 .
[13]	路露1 ,徐延山1 ,李岩1 ,2 ,亢雷1 ,2 ,谢士勇1 ,2 . 急性中心性浆液性脉络膜视网膜病变黄斑区形态学改变与视功能的关系[J]. , 2011, 39(5): 394-397 .
[14]	刘昞莉. 中心性浆液性脉络膜视网膜病变的三维光学相干断层扫描的临床分析[J]. , 2011, 39(2): 179-180 .